Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Grant/Award of 10,000 SPRO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 10,000 | n/a |
| May 20, 2026 | MACROGENICS INC (MGNX) | Exercise/Conversion | 3,750 | n/a |
| Jun 17, 2025 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| May 22, 2025 | MACROGENICS INC (MGNX) | Exercise/Conversion | 6,500 | n/a |
| Jun 3, 2024 | Mural Oncology plc (MURA) | Grant/Award | 8,462 | $28.3K |
| May 30, 2024 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| May 23, 2024 | MACROGENICS INC (MGNX) | Grant/Award | 6,500 | n/a |
| May 22, 2024 | MACROGENICS INC (MGNX) | Exercise/Conversion | 4,500 | n/a |
| May 1, 2024 | GLYCOMIMETICS INC (GLYC) | Grant/Award | 40,000 | n/a |
| Oct 10, 2023 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |